Body
Targeted hormone analysis for women covering estrogen, progesterone, testosterone, thyroid markers, and related metabolites. Essential for menopause management, fertility planning, and hormonal optimization.
Price on consultation
Book Your PRIME ProfileOVERVIEW
The Female Hormone Panel is a targeted blood analysis measuring the key hormones that regulate reproductive health, metabolic function, bone density, mood, energy, and skin quality in women. Hormonal balance is not a luxury concern — it is a fundamental driver of how women feel, function, and age.
The WunderLife Female Hormone Panel includes estradiol (E2), the primary active estrogen; progesterone, essential for cycle regulation and pregnancy support; testosterone (total and free), which influences energy, libido, and muscle maintenance in women; DHEA-S, an adrenal hormone precursor; sex hormone-binding globulin (SHBG), which affects how much active hormone is available to tissues; thyroid markers including TSH, free T3, free T4, and thyroid antibodies (TPO, TG); follicle-stimulating hormone (FSH) and luteinizing hormone (LH) for ovarian function assessment; and prolactin where clinically indicated.
At WunderLife in Bad Vilbel, near Frankfurt, Dr. med. Désirée Grawunder orders hormone panels with specific timing considerations. Many female hormones fluctuate dramatically across the menstrual cycle, meaning a blood draw on the wrong day can produce misleading results. The panel is timed to your cycle phase for accuracy. For perimenopausal and postmenopausal patients, timing is less critical but interpretation requires understanding of the hormonal transition stage.
While menopause management is a common reason for hormone testing, the Female Hormone Panel is equally relevant for women in their 20s and 30s experiencing irregular cycles, unexplained fatigue, mood changes, or difficulty conceiving. Hormonal imbalances can appear at any age and often have cascading effects across multiple body systems.
THE PROCESS
Dr. med. Désirée Grawunder reviews your medical history, current symptoms, menstrual cycle status, and any previous hormone testing. For premenopausal women, she determines the optimal cycle day for blood draw. Estradiol and progesterone are typically tested during the luteal phase (days 19–21 of a 28-day cycle), while FSH and LH are often tested during the early follicular phase (days 2–5).
A venous blood sample is drawn at the WunderLife clinic or at a partnering laboratory. The draw takes approximately 5 to 10 minutes. For premenopausal women, fasting is not always required for hormone markers specifically, but if the panel is combined with metabolic markers, fasting guidelines apply.
Samples are processed by an accredited German laboratory. Most hormone results return within 5 to 7 business days. Thyroid antibody results may take slightly longer.
Dr. Grawunder interprets all results in the context of your cycle phase, age, symptoms, and overall PRIME Profile. She correlates hormone levels with reported symptoms rather than treating numbers in isolation. A progesterone level that is technically within range but low for your cycle day, for example, tells a different clinical story than the number alone suggests.
Based on findings, Dr. Grawunder may recommend lifestyle and nutritional interventions targeting specific hormonal imbalances, adjustments to your WunderRise and WunderReset protocols to support hormonal health, referral for specialized endocrine care if indicated, and follow-up testing at specific intervals to track hormonal changes over time.
IDEAL CANDIDATES
The Female Hormone Panel is appropriate for any woman who wants objective insight into her hormonal health, whether she is experiencing specific symptoms or establishing a preventive baseline.
Women experiencing perimenopause or menopause symptoms including hot flashes, night sweats, sleep disruption, mood changes, and vaginal dryness. Those with irregular, absent, or painful menstrual cycles. Women experiencing unexplained fatigue, weight changes, or mood fluctuations. Patients with fertility concerns or those planning pregnancy. Women with a family history of thyroid disease, polycystic ovary syndrome (PCOS), or early menopause. Those experiencing hair thinning, skin changes, or reduced libido. Women in their 30s and 40s who want a baseline before hormonal transitions begin. Patients whose PRIME Profile assessment suggests hormonal factors may be contributing to their concerns.
Women currently taking hormonal contraceptives should discuss timing with Dr. med. Désirée Grawunder, as some markers are affected by exogenous hormones. Patients seeking acute gynecological care should consult their gynecologist directly.
YOUR EXPERIENCE
For premenopausal women, the blood draw is scheduled on a specific cycle day determined by Dr. med. Désirée Grawunder. Track your cycle and confirm the draw date with the clinic. Fasting may or may not be required depending on whether additional metabolic markers are included.
A standard venous blood draw from your arm taking approximately 5 to 10 minutes. Multiple tubes may be needed to cover all hormone and thyroid markers.
Resume all normal activities immediately. No restrictions on diet, exercise, or daily routine.
Most hormone results return within 5 to 7 business days. Dr. Grawunder schedules a results review appointment to walk through each marker, explain its significance in the context of your cycle phase and symptoms, and discuss any recommended interventions or monitoring.
SAFETY & SCIENCE
The Female Hormone Panel is a standard diagnostic blood test with minimal physical risk.
Blood is drawn using sterile, single-use equipment. Brief discomfort and minor bruising are the only common effects.
All samples are processed by accredited German laboratories using validated hormone immunoassays.
Female hormone levels are inherently dynamic. Estradiol can vary tenfold across a single menstrual cycle. Interpreting results without considering cycle timing, age, contraceptive use, and clinical context leads to misdiagnosis and inappropriate treatment. Dr. med. Désirée Grawunder integrates all of these factors into her interpretation, which is why physician-led analysis is essential for hormone testing.
WunderLife provides diagnostic hormone assessment and lifestyle or nutritional optimization. If results suggest conditions requiring specialized endocrine or gynecological management, Dr. Grawunder refers to appropriate specialists while continuing to coordinate care within the PRIME Protocol framework.
All results are stored in compliance with DSGVO/GDPR regulations as part of your confidential medical record.
THE PRIME PROTOCOL
The Female Hormone Panel sits within the Body pillar of the BAM Framework and directly addresses one of the most common drivers of how women experience aging, energy, and overall vitality.
The panel is an essential Profile-phase diagnostic for any female patient whose symptoms, age, or goals suggest hormonal factors. The data establishes a hormonal baseline that informs treatment decisions across all three BAM pillars.
Identified imbalances trigger Repair-phase interventions. Thyroid dysfunction, low progesterone, or declining estradiol may be addressed through targeted supplementation via WunderRise, lifestyle modifications, or referral for hormone therapy where clinically appropriate.
For women in perimenopause or menopause, longitudinal hormone tracking during the Maintain phase allows Dr. med. Désirée Grawunder to monitor the pace of hormonal transition and adjust support accordingly. This is especially valuable for women whose aesthetic and body treatments are influenced by hormonal status.
The Enhance phase may incorporate advanced hormonal optimization strategies for women whose baseline has been stabilized. This could include targeted adrenal support, thyroid optimization within functional ranges, or coordination with hormone replacement therapy if initiated by an endocrinologist.
FREQUENTLY ASKED QUESTIONS
Timing depends on which hormones are being tested. Estradiol and progesterone are typically tested during the luteal phase (days 19 to 21 of a 28-day cycle). FSH and LH are often tested early in the cycle (days 2 to 5). Dr. med. Désirée Grawunder determines the optimal timing based on your specific panel and clinical question.
Hormonal contraceptives suppress your natural hormone production, which means results will reflect the synthetic hormones rather than your endogenous levels. Dr. Grawunder discusses the implications and may recommend testing during a break from contraception if a baseline assessment of natural levels is needed.
Standard gynecological hormone testing often includes a limited panel focused on specific clinical questions. The WunderLife Female Hormone Panel is broader, includes thyroid and adrenal markers, and is interpreted within the context of your complete PRIME Profile rather than in isolation.
Yes. Estrogen influences skin hydration, collagen production, and elasticity. Testosterone affects sebum production and acne. Thyroid function impacts hair quality, skin texture, and weight. Hormonal assessment is directly relevant to aesthetic treatment planning, which is why the BAM Framework connects Body and Aesthetic pillars.
The standard PRIME Profile blood work is included in all memberships. The Female Hormone Panel as a specialized add-on is priced separately. Pricing is confirmed during your consultation.
For perimenopausal women, retesting every 6 to 12 months allows tracking of the hormonal transition. For premenopausal women with identified imbalances, retesting 8 to 12 weeks after intervention confirms response. Once stable, annual testing is usually sufficient.
READY TO BEGIN?
Every treatment at WunderLife begins with understanding. Your PRIME Profile maps your biology, your goals, and your path forward.
Book Your PRIME Profile
